SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?


To: keokalani'nui who wrote (6588)6/18/2002 8:41:06 PM
From: Miljenko Zuanic  Read Replies (2) | Respond to of 52153
 
I am not that enthusiastic on Pralnacasan as you are.

Data are at borderline efficacy (for MILD to MODERATE RA), while pts on MTX <6 months fire worse with P than with placebo.
Second 1200 mg and *very potent* are not going together very well. Friend pointed to me on potentially significant problem with P-like structure. P is pro-drug, so I *see* significant deviation in PK.

Miljenko